N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide (Compound)

Synonyms:MGCD-265, 875337-44-3, N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide, n-(3-fluoro-4-(2-(1-methyl-1h-imidazol-4-yl)thieno(3,2-b)pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide, CHEMBL254760, N-((3-Fluoro-4-((2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)carbamothioyl)-2-phenylacetamide, 93M6577H9D, Benzeneacetamide, N-(((3-fluoro-4-((2-(1-methyl-1H-imidazol-4-yl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)amino)thioxomethyl)-, N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide, N-[(3-Fluoro-4-{[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)carbamothioyl]-2-phenylacetamide, UNII-93M6577H9D, MLS006010962, SCHEMBL3576588, BDBM24498, CHEBI:91393, DTXSID60647874, EX-A051, BCPP000164, HMS3295E15, HMS3654P17, AMY24155, BCP02390, MFCD17779287, NSC800790, s1361, AKOS015904513, BCP9000924, CCG-269835, CS-0188, NSC-800790, NCGC00346510-01, NCGC00346510-04, AC-32063, AS-75067, HY-10991, SMR004702766, FT-0746707, SW219463-1, thieno[3,2-b]pyridine-based inhibitor, 10a, J-523005, BRD-K56277358-001-01-8, Q27077814, 1-(3-fluoro-4-{[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-3-(2-phenylacetyl)thiourea, 3-(3-fluoro-4-{[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-(2-phenylacetyl)thiourea, N-(3-Fluoro-4-{[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-N'-(phenylacetyl)thiourea, N-[[[3-Fluoro-4-[[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]benzeneacetamide

Pubchem:PUBCHEM:24901704

Id:c5854f9c-fa35-589d-a539-10a0a0875f38

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide.

Results found

Linked to

	Label	Description
	BRD-K56277358-001-07-5 Substance (Entity type)	A Substance
	mgcd-265 (33899560-ee18-48c8-bee3-aca4066ad1f9) Collection (Entity type)	Metadatata for mgcd-265
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide in similarity relationship with (4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide negatively regulates MT1HL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide positively regulates PTX3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide positively regulates EIF5A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide negatively regulates SCGB2A2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide in similarity relationship with SID103905568 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide positively regulates MAGEA12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide positively regulates BAD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K56277358-001-07-5

Substance (Entity type)

A Substance

mgcd-265 (33899560-ee18-48c8-bee3-aca4066ad1f9)

Collection (Entity type)

Metadatata for mgcd-265

N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide in similarity relationship with (4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine

Knowledge Graph Assertion (Entity type)